Genetic modification of human adipose-derived stem cells for promoting wound healing

Journal of Dermatological Science

Volumn 66, Issue 2, 2012, Pages 98-107

  Song, Seung Hyun ^a   Lee, Mi Ok ^a   Lee, Ji Seon ^a   Jeong, Ho Chang ^a   Kim, Hyung Gi ^d   Kim, Won Serk ^b   Hur, Mina ^c   Cha, Hyuk Jin ^a  

^a Sogang University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Konkuk University   (South Korea)

^d Proteomics Research Institute Seoul   (South Korea)

Author keywords

Conditioned medium; Genetic modification; Human adipose derived stem cells; V myc; Wound healing

Indexed keywords

GROWTH FACTOR; ONCOPROTEIN; PROTEIN KINASE B; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA MODIFICATION; ENDOTHELIUM CELL; FEASIBILITY STUDY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE MYC; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN INJURY; STEM CELL TRANSPLANTATION; WOUND HEALING;

ADIPOCYTES; ADULT STEM CELLS; ANIMALS; CELL PROLIFERATION; COCULTURE TECHNIQUES; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, MYC; HUMANS; MICE; MICE, HAIRLESS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; SKIN; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84859783335     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.02.010     Document Type: Article

References (51)

1. Fraser J.K., Schreiber R., Strem B., Zhu M., Alfonso Z., Wulur I., et al. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med 2006, 3(Suppl. 1):S33-S37.
2. Ning H., Lin G., Lue T.F., Lin C.S. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 2006, 74:510-518.
3. Casteilla L., Planat-Benard V., Laharrague P., Cousin B. Adipose-derived stromal cells: their identity and uses in clinical trials, an update. World J Stem Cells 2011, 3:25-33.
4. Zolochevska O., Yu G., Gimble J.M., Figueiredo ML Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev 2011, Jul 26. [Epub ahead of print].
5. Choi E.W., Shin I.S., Lee H.W., Park S.Y., Park J.H., Nam M.H., et al. Transplantation of CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis. J Gene Med 2011, 13:3-16.
6. Heo S.C., Jeon E.S., Lee I.H., Kim H.S., Kim M.B., Kim J.H. Tumor necrosis factor-alpha-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol 2011, 131:1559-1567.
7. Salgado A.J., Reis R.L., Sousa N.J., Gimble J.M. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 2010, 5:103-110.
8. Skalnikova H., Motlik J., Gadher S.J., Kovarova H. Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2011, 11:691-708.
9. Kilroy G.E., Foster S.J., Wu X., Ruiz J., Sherwood S., Heifetz A., et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212:702-709.
10. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846.
11. Kim M.H., Hong H.N., Hong J.P., Park C.J., Kwon S.W., Kim S.H., et al. The effect of VEGF on the myogenic differentiation of adipose tissue derived stem cells within thermosensitive hydrogel matrices. Biomaterials 2010, 31:1213-1218.
12. Lee E.Y., Xia Y., Kim W.S., Kim M.H., Kim T.H., Kim K.J., et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 2009, 17:540-547.
13. Song S.Y., Chung H.M., Sung J.H. The pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration. Expert Opin Biol Ther 2010, 10:1529-1537.
14. Noer A., Lindeman L.C., Collas P. Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells. Stem Cells Dev 2009, 18:725-736.
15. Lee J.S., Lee M.O., Moon B.H., Shim S.H., Fornace A.J., Cha H.J. Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways. Stem Cells 2009, 27:1963-1975.
16. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., et al. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 1998, 16:1033-1039.
17. Kim S.U. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004, 24:159-171.
18. Lee H.J., Kim M.K., Kim H.J., Kim S.U. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS ONE 2009, 4:e5586.
19. Kim W.S., Park B.S., Kim H.K., Park J.S., Kim K.J., Choi J.S., et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 2008, 49:133-142.
20. Park B.S., Jang K.A., Sung J.H., Park J.S., Kwon Y.H., Kim K.J., et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al.] 2008, 34:1323-1326.
21. Kim W.S., Park B.S., Sung J.H., Yang J.M., Park S.B., Kwak S.J., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007, 48:15-24.
22. Lee J.S., Lee H.J., Moon B.H., Song S.H., Lee M.O., Shim S.H., et al. Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation. Stem Cell Rev 2011, Jul 14. [Epub ahead of print].
23. Kim J.Y., Song S.H., Kim K.L., Ko J.J., Im J.E., Yie S.W., et al. Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplant 2010, 19:1635-1644.
24. Ryder E.F., Snyder E.Y., Cepko C.L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J Neurobiol 1990, 21:356-375.
25. Birren S.J., Anderson D.J. A v-myc-immortalized sympathoadrenal progenitor cell line in which neuronal differentiation is initiated by FGF but not NGF. Neuron 1990, 4:189-201.
26. Lo L.C., Birren S.J., Anderson D.J. V-myc immortalization of early rat neural crest cells yields a clonal cell line which generates both glial and adrenergic progenitor cells. Dev Biol 1991, 145:139-153.
27. De Filippis L., Ferrari D., Rota Nodari L., Amati B., Snyder E., Vescovi A.L. Immortalization of human neural stem cells with the c-myc mutant T58A. PLoS ONE 2008, 3:e3310.
28. Nagai A., Kim W.K., Lee H.J., Jeong H.S., Kim K.S., Hong S.H., et al. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE 2007, 2:e1272.
29. Pelengaris S., Khan M., Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2:764-776.
30. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006, 98:1076-1084.
31. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
32. Nie C., Yang D., Xu J., Si Z., Jin X., Zhang J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011, 20(2):205-216.
33. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
34. Ahmed N.N., Franke T.F., Bellacosa A., Datta K., Gonzalez-Portal M.E., Taguchi T., et al. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 1993, 8:1957-1963.
35. Chen Q., Fischer A., Reagan J., Yan L., Ames B. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 1995, 92:4337-4341.
36. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000, 60:1541-1545.
37. Pore N., Liu S., Shu H.K., Li B., Haas-Kogan D., Stokoe D., et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 2004, 15:4841-4853.
38. Ripoll C.B., Flaat M., Klopf-Eiermann J., Fisher-Perkins J.M., Trygg C.B., Scruggs B.A., et al. Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease. Stem Cells 2011, 29:67-77.
39. Chen Y.T., Sun C.K., Lin Y.C., Chang L.T., Chen Y.L., Tsai T.H., et al. Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med 2011, 9:51.
40. Razmkhah M., Jaberipour M., Erfani N., Habibagahi M., Talei A.R., Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?. Cell Immunol 2011, 266:116-122.
41. Zhang X., Soda Y., Takahashi K., Bai Y., Mitsuru A., Igura K., et al. Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochem Biophys Res Commun 2006, 351:853-859.
42. Abdallah B.M., Haack-Sorensen M., Burns J.S., Elsnab B., Jakob F., Hokland P., et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 2005, 326:527-538.
43. Daksis J.I., Lu R.Y., Facchini L.M., Marhin W.W., Penn L.J. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 1994, 9:3635-3645.
44. Perez-Roger I., Solomon D.L., Sewing A., Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 1997, 14:2373-2381.
45. Hanson K.D., Shichiri M., Follansbee M.R., Sedivy J.M. Effects of c-myc expression on cell cycle progression. Mol Cell Biol 1994, 14:5748-5755.
46. McIntosh K., Zvonic S., Garrett S., Mitchell J.B., Floyd Z.E., Hammill L., et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006, 24:1246-1253.
47. Yu J.M., Jun E.S., Bae Y.C., Jung J.S. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008, 17:463-473.
48. Park J.S., Kim H.Y., Kim H.W., Chae G.N., Oh H.T., Park J.Y., et al. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev 2005, 126:551-559.
49. Song Y.H., Gehmert S., Sadat S., Pinkernell K., Bai X., Matthias N., et al. VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun 2007, 354:999-1003.
50. Kawasaki K., Smith R.S., Hsieh C.M., Sun J., Chao J., Liao J.K. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 2003, 23:5726-5737.
51. Deregibus M.C., Buttiglieri S., Russo S., Bussolati B., Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem 2003, 278:18008-18014.